| Literature DB >> 32579326 |
Micah Dettweiler1, Roberta J Melander2, Gina Porras3, Caitlin Risener4, Lewis Marquez4, Tharanga Samarakoon5, Christian Melander2, Cassandra L Quave1,3,4.
Abstract
The rise of antibiotic resistance presents a significant healthcare challenge and precludes the use of many otherwise valuable antibiotics. One potential solution to this problem is the use of antibiotics in combination with resistance-modifying agents, compounds that act synergistically with existing antibiotics to resensitize previously resistant bacteria. In this study, 12(S),16ξ-dihydroxycleroda-3,13-dien-15,16-olide, a clerodane diterpene isolated from the medicinal plant Callicarpa americana, was found to synergize with oxacillin against methicillin-resistant Staphylococcus aureus. This synergy was confirmed by checkerboard (fractional inhibitory concentration index (FICI) = 0.125) and time-kill assays, with a subinhibitory dose of 12(S),16ξ-dihydroxycleroda-3,13-dien-15,16-olide causing the effective concentration of oxacillin to fall below the susceptibility breakpoint for S. aureus, a >32-fold decrease in both cases.Entities:
Keywords: MRSA; botanical; natural product; oxacillin; synergy; terpene
Year: 2020 PMID: 32579326 DOI: 10.1021/acsinfecdis.0c00307
Source DB: PubMed Journal: ACS Infect Dis ISSN: 2373-8227 Impact factor: 5.084